5AM Venture Management »

Biohaven shares owned by 5AM Venture Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by 5AM Venture Management from 13F filings

Historical chart of 5AM Venture Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by 5AM Venture Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by 5AM Venture Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 400k 42.80

More positions owned by 5AM Venture Management

Enliven Therapeutics (ELVN)
Entrada Therapeutics (TRDA)
Pharvaris N V (PHVS)
Celldex Therapeutics Com New (CLDX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Biohaven (BHVN)
Disc Medicine (IRON)
Dianthus Therapeutics (DNTH)
Merus N V (MRUS)
Vor Biopharma (VOR)
Miragen Therapeutics (VRDN)
Mirati Therapeutics
Viking Therapeutics (VKTX)
Rallybio Corp (RLYB)
Tyra Biosciences (TYRA)

View all positions for 5AM Venture Management

Top funds holding Biohaven

Vanguard Group
Stifel Financial
Henderson Group
BlackRock
T. Rowe Price Associates
RP Management
Point72 Asset Management
Perceptive Advisors
Redmile Group
Holocene Advisors
Citadel Advisors
Avidity Partners Management
Bellevue Group
Goldman Sachs Group
Oracle Investment Management

View all funds holding Biohaven